Bio

Carolyn Horn joined Needham & Company in 2015 and Co-Head of Needham’s Healthcare Investment Banking Group. With a focus on emerging growth companies in the biotech and medtech sectors, Carolyn advises on both public and private financings including IPOs, follow-on offerings, convertible debt, and private placements. Prior to her current role at Needham, Carolyn was Head of Healthcare Equity Capital Markets, where she led the origination and execution of all life sciences equities transactions at the firm. Carolyn has more than 15 years of experience working with life sciences companies and providing investment banking and capital markets advisory services. Prior to joining Needham, Carolyn was a Healthcare Sector Specialist in Institutional Equity Sales at JMP Securities. Earlier in her career, she was part of the Emerging Companies group at the Biotechnology Innovation Organization (BIO) in Washington DC. Carolyn received her B.A. in Biology and International Studies, with a premed concentration, from Washington University in St. Louis.